Cancer Letters
Volume 291, Issue 2 , Pages 209-216 , 28 May 2010

Repeated hepatocyte growth factor neutralizing antibody treatment leads to HGF/SF unresponsiveness in human glioblastoma multiforme cells

  • Ping Zhao

      Affiliations

    • Nanjing Medical University Cancer Center, Key Laboratory of Antibody Technology of Ministry of Health, Nanjing, China
    • Van Andel Research Institute, Grand Rapids, MI, USA
  • ,
  • Chongfeng Gao

      Affiliations

    • Van Andel Research Institute, Grand Rapids, MI, USA
  • ,
  • Karl Dykema

      Affiliations

    • Van Andel Research Institute, Grand Rapids, MI, USA
  • ,
  • Kyle Furge

      Affiliations

    • Van Andel Research Institute, Grand Rapids, MI, USA
  • ,
  • Zhenqing Feng

      Affiliations

    • Nanjing Medical University Cancer Center, Key Laboratory of Antibody Technology of Ministry of Health, Nanjing, China
    • Corresponding Author InformationCorresponding authors. Addresses: Van Andel Institute, 333 Bostwick Ave., NE, Grand, Rapids, MI 49503, USA. Tel.: +1 616 234 5342; fax: +1 616 234 5343 (B. Cao), Department of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029, China. Tel.: +86 25 8686 2011 (Z. Feng).
  • ,
  • Brian Cao

      Affiliations

    • Nanjing Medical University Cancer Center, Key Laboratory of Antibody Technology of Ministry of Health, Nanjing, China
    • Van Andel Research Institute, Grand Rapids, MI, USA
    • Corresponding Author InformationCorresponding authors. Addresses: Van Andel Institute, 333 Bostwick Ave., NE, Grand, Rapids, MI 49503, USA. Tel.: +1 616 234 5342; fax: +1 616 234 5343 (B. Cao), Department of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029, China. Tel.: +86 25 8686 2011 (Z. Feng).

Received 16 July 2009 ,Revised 9 October 2009 ,Accepted 19 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(09)00636-3

doi: 10.1016/j.canlet.2009.10.014

Cancer Letters
Volume 291, Issue 2 , Pages 209-216 , 28 May 2010